BRIEF: Jinxin Fertility’s business improves in fourth quarter

1951.HK
Jinxin does health AI

Fertility services provider Jinxin Fertility Group Ltd. (1951.HK) provided 7,004 in vitro fertilization (IVF) treatments to its customers in last year’s fourth quarter, up 12% from a year earlier, according to calculations based on data released by the company on Monday. The strong gain showed the company’s business is rebounding after a weak start to 2025.

After adding in the strong fourth-quarter performance, the company’s total IVF treatments for all of 2025 fell 1.4% year-on-year to 28,039, improving from a 5.2% decline in the first nine months of last year.

IVF treatments provided by the company’s Chengdu flagship rose 1.3% year-on-year to 14,070 for all 2025, equal to roughly half of its total. But treatments provided by its overseas operations fell 6.9% for the year to 4,235, as the company closed its IVF treatment center in Laos, reducing its overseas business to just the U.S.

Jinxin Fertility’s stock was up slightly at HK$2.50 in early afternoon trading on Tuesday. The shares are down about 5% over the last 52 weeks.

By Doug Young

To subscribe to Bamboo Works weekly free newsletter, click here

,
,

Related Articles

RELATED ARTICLES

  1. Jinxin provides fertility services
    Falling global birth rates drag Jinxin into the red
    1951.HK
  2. A strong quarter doesn’t make Yeahka a bargain
    9923.HK
  3. New Oriental turns in mixed report card of rising revenue, falling profits
    9901.HK
    EDU.US
  4. Transforming Qian Xun adds polish to new business with crypto cachet
  5. Noah finds second life in overseas voyage
    6686.HK
    NOAH.US
  6. Nanhua cleared to ride heightened market volatility to Hong Kong IPO
    603093.SHG
  7. Hello Group takes ‘Cyrano approach’ in bid to rekindle China’s dating interest
    MOMO.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

Meta acquires Manus

Meta cuts Manus free from China, as regional lender gets premium bailout

In a landmark validation for Chinese AI, Facebook parent Meta has agreed to buy general AI agent maker Manus. But why is Meta also quite vehement about cutting all of Manus' China ties, both in terms of investors and business activity? And regional Chinese lender Weihai Bank has just received a major cash infusion from its local government in Shandong province. Is this a worrisome sign for investors?
META.US